Abstract
A non-sulfhydryl-containing inhibitor of angiotensin-converting enzyme (MK421) was given as a single dose in a randomised double-blind cross-over trial using 20 mg and 5 mg of MK-421 or matched placebo to nine normotensive volunteers receiving a sodium intake of 150 mmol (mEq) daily. The two dosages of MK-421 caused similar, significant falls in supine and standing blood pressure, which were maximum four to six hours after dosing (9.5-11.0% fall). With this fall in blood pressure there was a significant fall in activity of angiotensin-converting enzyme and in concentrations of plasma angiotensin II and aldosterone and a rise in plasma renin activity. Placebo caused no significant change in blood pressure or blood measurements. The study showed that MK-421 inhibits angiotensin-converting enzyme activity and lowers blood pressure in normotensive subjects. It strongly suggested that the renin system plays an important part in maintaining blood pressure in normotensive subjects receiving normal sodium intake. The results also suggest that this non-sulfhydryl-containing converting-enzyme inhibitor will be an effective blood-pressure-lowering drug in patients with blood pressure. A single dose of 5 mg was as effective at lowering blood pressure as a single dose of 20 mg.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Düsterdieck G., McElwee G. Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states. Eur J Clin Invest. 1971 Nov;2(1):32–38. doi: 10.1111/j.1365-2362.1971.tb00565.x. [DOI] [PubMed] [Google Scholar]
- George C. F., Lewis P. J., Petrie A. Clinical experience with use of ultrasound sphygmomanometer. Br Heart J. 1975 Aug;37(8):804–807. doi: 10.1136/hrt.37.8.804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haber E. George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis. Circulation. 1976 Dec;54(6):849–861. doi: 10.1161/01.cir.54.6.849. [DOI] [PubMed] [Google Scholar]
- Joy M. D., Lowe R. D. Evidence that the area postrema mediates the central cardiovascular response to angiotensin II. Nature. 1970 Dec 26;228(5278):1303–1304. doi: 10.1038/2281303a0. [DOI] [PubMed] [Google Scholar]
- MacGregor G. A., Markandu N. D., Roulston J. E., Jones J. C. Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme. Br Med J. 1979 Nov 3;2(6198):1106–1109. doi: 10.1136/bmj.2.6198.1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacGregor G. A., Markandu N. D., Roulston J. E., Jones J. C., Morton J. J. Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature. 1981 May 28;291(5813):329–331. doi: 10.1038/291329a0. [DOI] [PubMed] [Google Scholar]
- Patchett A. A., Harris E., Tristram E. W., Wyvratt M. J., Wu M. T., Taub D., Peterson E. R., Ikeler T. J., ten Broeke J., Payne L. G. A new class of angiotensin-converting enzyme inhibitors. Nature. 1980 Nov 20;288(5788):280–283. doi: 10.1038/288280a0. [DOI] [PubMed] [Google Scholar]
- Prins E. J., Hoorntje S. J., Weening J. J., Donker A. J. Nephrotic syndrome in patient on captopril. Lancet. 1979 Aug 11;2(8137):306–307. doi: 10.1016/s0140-6736(79)90322-2. [DOI] [PubMed] [Google Scholar]
- Roulston J. E., MacGregor G. A. Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage. Clin Chim Acta. 1978 Aug 15;88(1):45–48. doi: 10.1016/0009-8981(78)90147-x. [DOI] [PubMed] [Google Scholar]
- Vlasses P. H., Ferguson R. K. Temporary ageusia related to captopril. Lancet. 1979 Sep 8;2(8141):526–526. doi: 10.1016/s0140-6736(79)91579-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Brummelen P., Willemze R., Tan W. D., Thompson J. Captopril-associated agranulocytosis. Lancet. 1980 Jan 19;1(8160):150–150. doi: 10.1016/s0140-6736(80)90629-7. [DOI] [PubMed] [Google Scholar]